Rafaela de Siqueira Ferraz Carvalho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rafaela de Siqueira Ferraz Carvalho has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Nereide Stela Santos-Magalhães
Keizo Asami Institute, iLIKA, Federal University of Pernambuco Recife Brazil
5 shared publications - Isabella Macário Ferro Cavalcanti
Federal University of Pernambuco (UFPE)
4 shared publications - Marcela Araújo Pereira
Universidade Federal de Pernambuco
3 shared publications - Amanda Vasconcelos de Albuquerque
Post-graduation Program in Surgery, Department of Surgery, Federal University of Pernambuco, Pernambuco, Brazil
2 shared publications - Mariane Cajubá de Britto Lira Nogueira
Universidade Federal de Pernambuco (UFPE)
2 shared publications - Alessandra Silva Araujo
Universidade Federal de Pernambuco
1 shared publication
Latest Publications
- Open Access
- 26 September 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (13)
Avaliação do conhecimento de universitários de Vitória de Santo Antão sobre a sífilis
O objetivo deste estudo foi avaliar o nível de conhecimento de universitários de Vitória de Santo Antão sobre a sífilis. Trata-se de uma pesquisa exploratória transversal com abordagem quantitativa e qualitativa, realizada com os estudantes universitários em Vitória de Santo Antão, Pernambuco, através da aplicação de um questionário. Esse questionário possuía 39 questões objetivas e 3 subjetivas para avaliar o nível de conhecimento dos estudantes sobre a sífilis, estimando a prevalência de infecção por sífilis entre os estudantes e relacionando a presença da infecção com as condições socioeconômica e demográfica dos estudantes. Os participantes dessa pesquisa demonstraram ter conhecimento suficiente sobre a sífilis sabendo diferenciar os três estágios e como a infecção é transmitida e prevenida. Apesar de, em sua maioria, os participantes da pesquisa declararem não utilizar o preservativo em todas as relações que praticam, e não terem sido testados nos três meses anteriores à pesquisa, foi possível observar que eles possuem o conhecimento sobre os sintomas de cada fase e as melhores formas de prevenção. Embora constatado que o conhecimento dos universitários sobre a sífilis era suficiente a partir da análise das respostas do questionário, ainda pôde ser vista a necessidade de promoção de ações de sensibilização e construção do pensamento crítico quanto ao pôr em prática o sexo seguro.
- 26 September 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (13)
Open AccessAvaliação do conhecimento de universitários de Vitória de Santo Antão sobre a sífilis
O objetivo deste estudo foi avaliar o nível de conhecimento de universitários de Vitória de Santo Antão sobre a sífilis. Trata-se de uma pesquisa exploratória transversal com abordagem quantitativa e qualitativa, realizada com os estudantes universitários em Vitória de Santo Antão, Pernambuco, através da aplicação de um questionário. Esse questionário possuía 39 questões objetivas e 3 subjetivas para avaliar o nível de conhecimento dos estudantes sobre a sífilis, estimando a prevalência de infecção por sífilis entre os estudantes e relacionando a presença da infecção com as condições socioeconômica e demográfica dos estudantes. Os participantes dessa pesquisa demonstraram ter conhecimento suficiente sobre a sífilis sabendo diferenciar os três estágios e como a infecção é transmitida e prevenida. Apesar de, em sua maioria, os participantes da pesquisa declararem não utilizar o preservativo em todas as relações que praticam, e não terem sido testados nos três meses anteriores à pesquisa, foi possível observar que eles possuem o conhecimento sobre os sintomas de cada fase e as melhores formas de prevenção. Embora constatado que o conhecimento dos universitários sobre a sífilis era suficiente a partir da análise das respostas do questionário, ainda pôde ser vista a necessidade de promoção de ações de sensibilização e construção do pensamento crítico quanto ao pôr em prática o sexo seguro.
- Open Access
- 16 January 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (2)
Utilização de aminoglicosídeos como estratégia terapêutica para combater infecções causadas por enterobactérias produtoras de β-lactamases de espectro estendido
The treatment of infections caused by enterobacteria that produce extended-spectrum β-lactamases enzymes (ESBLs) is increasingly challenging, so that the indiscriminate and exacerbated use of antibiotics has promoted bacterial resistance and dissemination of these pathogens, making the treatment of these bacteria a public health challenge. Taking into account that aminoglycosides are the antibiotics indicated for the clinical treatment of infections caused by enterobacteria, the objective of this review was to describe the use and effectiveness of aminoglycosides as a therapeutic strategy to combat infections caused by enterobacteria that produce ESBLs. A bibliographic review was carried out through searches in PubMed, Scientific Electronic Library On-line (SCIELO) and Google Scholar databases, selecting articles published between 2011 and 2020, in English, with the following descriptors: Gram-negative bacteria, Resistance and Infections. The results showed that plazomycin is effective against strains of Citrobacter spp., Klebsiella spp. and Enterobacter spp. producing ESBLs, while gentamicin, tobramycin and apramycin are effective against E. coli, Burkholderia spp., Serratia spp., Citrobacter spp., Enterobacter spp. and Klebsiella spp. ESBL producers. Regarding the combination therapy, it can be observed that the combination between two aminoglycosides or between aminoglycosides and other antibiotics promoted a synergistic effect when compared with the monotherapy against E. coli, Enterobacter spp., Enterobacter cloacae and mainly Klebsiella pneumonia producing ESBLs. Therefore, aminoglycosides have shown great potential against this group of bacteria, which represent a great challenge for the medical profession.
- 16 January 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (2)
Open AccessUtilização de aminoglicosídeos como estratégia terapêutica para combater infecções causadas por enterobactérias produtoras de β-lactamases de espectro estendido
The treatment of infections caused by enterobacteria that produce extended-spectrum β-lactamases enzymes (ESBLs) is increasingly challenging, so that the indiscriminate and exacerbated use of antibiotics has promoted bacterial resistance and dissemination of these pathogens, making the treatment of these bacteria a public health challenge. Taking into account that aminoglycosides are the antibiotics indicated for the clinical treatment of infections caused by enterobacteria, the objective of this review was to describe the use and effectiveness of aminoglycosides as a therapeutic strategy to combat infections caused by enterobacteria that produce ESBLs. A bibliographic review was carried out through searches in PubMed, Scientific Electronic Library On-line (SCIELO) and Google Scholar databases, selecting articles published between 2011 and 2020, in English, with the following descriptors: Gram-negative bacteria, Resistance and Infections. The results showed that plazomycin is effective against strains of Citrobacter spp., Klebsiella spp. and Enterobacter spp. producing ESBLs, while gentamicin, tobramycin and apramycin are effective against E. coli, Burkholderia spp., Serratia spp., Citrobacter spp., Enterobacter spp. and Klebsiella spp. ESBL producers. Regarding the combination therapy, it can be observed that the combination between two aminoglycosides or between aminoglycosides and other antibiotics promoted a synergistic effect when compared with the monotherapy against E. coli, Enterobacter spp., Enterobacter cloacae and mainly Klebsiella pneumonia producing ESBLs. Therefore, aminoglycosides have shown great potential against this group of bacteria, which represent a great challenge for the medical profession.
- Open Access
- 4 December 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (16)
Segurança e eficácia da celulose bacteriana obtida a partir do melaço de cana-de-açúcar no processo de cicatrização e remodelamento tecidual: uma revisão narrativa
Este estudo teve como objetivo analisar a segurança e eficácia da celulose bacteriana (CB) produzida a partir do melaço de cana-de- açúcar, através de estudos conduzidos e publicados pelo Grupo de Pesquisa sobre Biopolímeros de Cana-de-Açúcar, vinculados à POLISA©, Biopolímeros para Saúde. Trata-se de uma revisão narrativa da literatura que foi conduzida a partir do acervo de publicações sobre biopolímero de cana-de-açúcar, vinculados à POLISA©, Biopolímeros para Saúde. Foram selecionados 21 estudos publicados entre os anos de 2002 a 2020, sendo 11 estudos relacionados à avaliação pré-clínica e 10 à avaliação clínica. Os estudos envolvendo a avaliação toxicológica e de biocompatibilidade descreveram a segurança e os riscos frente ao uso da CB, enquanto que os de avaliação clínica investigaram o processo de cicatrização e remodelamento tecidual, a fim de estimar a sua eficácia como curativo. De modo geral, a CB não demonstrou ser citotóxico, genotóxico ou agudamente tóxico, apresentando alta biocompatibilidade, além disso, mostrou-se eficaz ao induzir o processo de cicatrização e remodelamento tecidual.
- 4 December 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (16)
Open AccessSegurança e eficácia da celulose bacteriana obtida a partir do melaço de cana-de-açúcar no processo de cicatrização e remodelamento tecidual: uma revisão narrativa
Este estudo teve como objetivo analisar a segurança e eficácia da celulose bacteriana (CB) produzida a partir do melaço de cana-de- açúcar, através de estudos conduzidos e publicados pelo Grupo de Pesquisa sobre Biopolímeros de Cana-de-Açúcar, vinculados à POLISA©, Biopolímeros para Saúde. Trata-se de uma revisão narrativa da literatura que foi conduzida a partir do acervo de publicações sobre biopolímero de cana-de-açúcar, vinculados à POLISA©, Biopolímeros para Saúde. Foram selecionados 21 estudos publicados entre os anos de 2002 a 2020, sendo 11 estudos relacionados à avaliação pré-clínica e 10 à avaliação clínica. Os estudos envolvendo a avaliação toxicológica e de biocompatibilidade descreveram a segurança e os riscos frente ao uso da CB, enquanto que os de avaliação clínica investigaram o processo de cicatrização e remodelamento tecidual, a fim de estimar a sua eficácia como curativo. De modo geral, a CB não demonstrou ser citotóxico, genotóxico ou agudamente tóxico, apresentando alta biocompatibilidade, além disso, mostrou-se eficaz ao induzir o processo de cicatrização e remodelamento tecidual.
- Open Access
- 30 June 2021
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 32 (7) , 1-10
Bacterial cellulose an effective material in the treatment of chronic venous ulcers of the lower limbs
Chronic venous ulcers (CVU) of the lower limbs (LL) are common and cause psychological changes and significant social impact, as they make the patient susceptible to pain, absence from work and social bonds. Some materials are suggested as dressings for the treatment of CVU, but they are expensive and are generally not available for use in public health services. To evaluate the efficacy of the treatment for lower limbs (LL) chronic venous ulcer (CVU) using bacterial cellulose (BC), gel and multi-perforated film associated. A randomized controlled clinical-intervention study was performed among participants with LL CVU, divided into two groups: experimental (EG), treated with BC wound dressing and control (CG), treated with a cellulose acetate mesh impregnated with essential fatty acids (Rayon®). The participants were followed for 180 days, evaluated according to the MEASURE methodology. Thirty-nine patients were treated, 20 from the EG and 19 from the CG. In both groups, the wound area decreased significantly (p < 0.001), the healing rate was similar to the CG. The mean number of dressing changes in the SG was 18.33 ± 11.78, while in the CG it was 55.24 ± 25.81, p < 0.001. The healing dressing of bacterial cellulose, gel and associated film, when stimulating the epithelization of the lesions, showed a significant reduction in the initial area, with a percentage of cure similar to the Rayon® coverage. In addition to requiring less direct manipulation of ulcers.
- 30 June 2021
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 32 (7) , 1-10
Open AccessBacterial cellulose an effective material in the treatment of chronic venous ulcers of the lower limbs
Chronic venous ulcers (CVU) of the lower limbs (LL) are common and cause psychological changes and significant social impact, as they make the patient susceptible to pain, absence from work and social bonds. Some materials are suggested as dressings for the treatment of CVU, but they are expensive and are generally not available for use in public health services. To evaluate the efficacy of the treatment for lower limbs (LL) chronic venous ulcer (CVU) using bacterial cellulose (BC), gel and multi-perforated film associated. A randomized controlled clinical-intervention study was performed among participants with LL CVU, divided into two groups: experimental (EG), treated with BC wound dressing and control (CG), treated with a cellulose acetate mesh impregnated with essential fatty acids (Rayon®). The participants were followed for 180 days, evaluated according to the MEASURE methodology. Thirty-nine patients were treated, 20 from the EG and 19 from the CG. In both groups, the wound area decreased significantly (p < 0.001), the healing rate was similar to the CG. The mean number of dressing changes in the SG was 18.33 ± 11.78, while in the CG it was 55.24 ± 25.81, p < 0.001. The healing dressing of bacterial cellulose, gel and associated film, when stimulating the epithelization of the lesions, showed a significant reduction in the initial area, with a percentage of cure similar to the Rayon® coverage. In addition to requiring less direct manipulation of ulcers.
- Open Access
- 17 May 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (6)
Interaction between bark extract of Anadenanthera colubrina var. cebil (Griseb.) Altschul with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA)
Anadenanthera colubrina var. cebil (Griseb.) Altschul, a plant often found in areas of the Caatinga in northeastern Brazil, is widely used in unconventional medicine for the treatment of infections and inflammations. Thus, the aim of the present study was to evaluate the antibacterial activity of A. colubrina bark extracts against methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, to investigate if intact and regenerated bark extracts have the same effect against MRSA and to determine the interaction between these extracts and antibiotics. The antibacterial activity was performed by the determination of the minimum inhibitory concentration (MIC) according to the Clinical and Laboratory Standards Institute (CLSI) and the interaction assay was performed by the checkerboard method. A. colubrina extracts showed bacteriostatic activity (MIC = 8-32 mg/L) against MRSA clinical strains and no difference was found in antibacterial activity between intact and regenerated barks, suggesting that even after regeneration, the barks of this species have the same antibacterial activity. Moreover, the in vitro interaction of A. colubrina extracts with ciprofloxacin or erythromycin was additive (FICI = 0.52). Thus, the bark extracts of Anadenanthera colubrina exhibit antibacterial activity and can be used alone or in combination with antibiotics against MRSA clinical isolates.
- 17 May 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (6)
Open AccessInteraction between bark extract of Anadenanthera colubrina var. cebil (Griseb.) Altschul with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA)
Anadenanthera colubrina var. cebil (Griseb.) Altschul, a plant often found in areas of the Caatinga in northeastern Brazil, is widely used in unconventional medicine for the treatment of infections and inflammations. Thus, the aim of the present study was to evaluate the antibacterial activity of A. colubrina bark extracts against methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, to investigate if intact and regenerated bark extracts have the same effect against MRSA and to determine the interaction between these extracts and antibiotics. The antibacterial activity was performed by the determination of the minimum inhibitory concentration (MIC) according to the Clinical and Laboratory Standards Institute (CLSI) and the interaction assay was performed by the checkerboard method. A. colubrina extracts showed bacteriostatic activity (MIC = 8-32 mg/L) against MRSA clinical strains and no difference was found in antibacterial activity between intact and regenerated barks, suggesting that even after regeneration, the barks of this species have the same antibacterial activity. Moreover, the in vitro interaction of A. colubrina extracts with ciprofloxacin or erythromycin was additive (FICI = 0.52). Thus, the bark extracts of Anadenanthera colubrina exhibit antibacterial activity and can be used alone or in combination with antibiotics against MRSA clinical isolates.
- 1 September 2020
- Published by Elsevier in Food Research International
- Vol. 135, 109295
Microencapsulation of Lactobacillus acidophilus La-05 and incorporation in vegan milks: Physicochemical characteristics and survival during storage, exposure to stress conditions, and simulated gastrointestinal digestion
- 1 September 2020
- Published by Elsevier in Food Research International
- Vol. 135, 109295
Microencapsulation of Lactobacillus acidophilus La-05 and incorporation in vegan milks: Physicochemical characteristics and survival during storage, exposure to stress conditions, and simulated gastrointestinal digestion
- 5 June 2020
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 35 (3) , 331-341
Use of bacterial cellulose film for repair of bile duct injury in pigs
The aim was to evaluate the use of bacterial cellulose film and bile duct autograft in repairing critical common bile duct injury in pigs. A prospective experimental analytical study was carried out on 20 Sus Domesticus, Piau suidae swine, divided into a control group (n = 10) and an experimental group (n = 10) divided into two subgroups: bacterial cellulose film E1 and bacterial cellulose film E2 to which bacterial cellulose film was randomly allocated. The control group underwent two complete critical common bile duct sections 10 mm apart, while the experimental group with a single critical common bile duct defect underwent a 10 mm section of the longitudinal shaft with edge resection. The defects in the control group were treated with end-to-end conventional anastomosis using polyglycolic 6–0 surgical thread and the experimental group with bacterial cellulose film by continuous suture using the same material. The animals were clinically evaluated throughout the experiment on days D150 (bacterial cellulose film E1), D225 (control group), and D330 (bacterial cellulose film E2) and by intraoperative ultrasound examination related to histopathological and biochemical findings. The intraoperative ultrasonography detected the changes resulting from the common bile duct anastomosis in the control group that produced a considerable incidence of ductal narrowing and obstruction to the biliary flow. In the bacterial cellulose film E2 group, there was an increase in inflammation intensity, granulomatous reaction, fibrosis, and vessels density, without producing bile duct dilation in the ultrasonography assessment. Biochemical analysis of liver enzymes yielded results in the normal range confirming preservation of liver function at the different post-surgery time points. Bacterial cellulose film, when used as a graft for bile duct repair, proved to be a biocompatible material that produced a complete healing process and biliary flow continuity.
- 5 June 2020
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 35 (3) , 331-341
Use of bacterial cellulose film for repair of bile duct injury in pigs
The aim was to evaluate the use of bacterial cellulose film and bile duct autograft in repairing critical common bile duct injury in pigs. A prospective experimental analytical study was carried out on 20 Sus Domesticus, Piau suidae swine, divided into a control group (n = 10) and an experimental group (n = 10) divided into two subgroups: bacterial cellulose film E1 and bacterial cellulose film E2 to which bacterial cellulose film was randomly allocated. The control group underwent two complete critical common bile duct sections 10 mm apart, while the experimental group with a single critical common bile duct defect underwent a 10 mm section of the longitudinal shaft with edge resection. The defects in the control group were treated with end-to-end conventional anastomosis using polyglycolic 6–0 surgical thread and the experimental group with bacterial cellulose film by continuous suture using the same material. The animals were clinically evaluated throughout the experiment on days D150 (bacterial cellulose film E1), D225 (control group), and D330 (bacterial cellulose film E2) and by intraoperative ultrasound examination related to histopathological and biochemical findings. The intraoperative ultrasonography detected the changes resulting from the common bile duct anastomosis in the control group that produced a considerable incidence of ductal narrowing and obstruction to the biliary flow. In the bacterial cellulose film E2 group, there was an increase in inflammation intensity, granulomatous reaction, fibrosis, and vessels density, without producing bile duct dilation in the ultrasonography assessment. Biochemical analysis of liver enzymes yielded results in the normal range confirming preservation of liver function at the different post-surgery time points. Bacterial cellulose film, when used as a graft for bile duct repair, proved to be a biocompatible material that produced a complete healing process and biliary flow continuity.
- Open Access
- 1 January 2018
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 81 (6) , 510-513
Ocular delivery of moxifloxacin-loaded liposomes
To determine the release profile of moxifloxacin encapsulated in liposomes in the aqueous humor as a controlled release system for intracameral application. Liposomes containing moxifloxacin were obtained using the lipid film hydration method and were characterized by particle size and encapsulation efficiency. Female rabbits were used for the in vivo profile release study. Liposomes containing moxifloxacin was injected into the anterior chamber of the right eye of each animal. The rabbits were divided into five groups, and a sample of aqueous humor was collected 2, 4, 8, 24, and 48 h after administration of liposomes containing moxifloxacin administration. Moxifloxacin concentrations in the aqueous humor were analyzed using high-performance liquid chromatography. The average size of the liposomes containing moxifloxacin was 60.5 ± 0.72 nm with a particle size distribution of 0.307. The encapsulation efficiency of moxifloxacin in liposomes was 92.24 ± 0.24%. The results of an in vivo release study of liposomes containing moxifloxacin, showed that the maximum moxifloxacin concentration was achieved within the first 2 h after administration (5.27 ± 1.09 mg/mL) and was followed by a decrease in intracameral concentration (0.35 ± 0.05 mg/mL) until the 24 h mark. The in vivo experiments resulted in liposomes containing moxifloxacin that were homogenous in size and exhibited high drug encapsulation efficiency. The results indicate that liposomes containing moxifloxacin offers a satisfactory aqueous humor release profile after intracameral application.
- 1 January 2018
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 81 (6) , 510-513
Open AccessOcular delivery of moxifloxacin-loaded liposomes
To determine the release profile of moxifloxacin encapsulated in liposomes in the aqueous humor as a controlled release system for intracameral application. Liposomes containing moxifloxacin were obtained using the lipid film hydration method and were characterized by particle size and encapsulation efficiency. Female rabbits were used for the in vivo profile release study. Liposomes containing moxifloxacin was injected into the anterior chamber of the right eye of each animal. The rabbits were divided into five groups, and a sample of aqueous humor was collected 2, 4, 8, 24, and 48 h after administration of liposomes containing moxifloxacin administration. Moxifloxacin concentrations in the aqueous humor were analyzed using high-performance liquid chromatography. The average size of the liposomes containing moxifloxacin was 60.5 ± 0.72 nm with a particle size distribution of 0.307. The encapsulation efficiency of moxifloxacin in liposomes was 92.24 ± 0.24%. The results of an in vivo release study of liposomes containing moxifloxacin, showed that the maximum moxifloxacin concentration was achieved within the first 2 h after administration (5.27 ± 1.09 mg/mL) and was followed by a decrease in intracameral concentration (0.35 ± 0.05 mg/mL) until the 24 h mark. The in vivo experiments resulted in liposomes containing moxifloxacin that were homogenous in size and exhibited high drug encapsulation efficiency. The results indicate that liposomes containing moxifloxacin offers a satisfactory aqueous humor release profile after intracameral application.
- Open Access
- 29 April 2016
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 111 (5) , 330-334
Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates
Mycobacterium tuberculosis (Mtb) has acquired resistance and consequently the antibiotic therapeutic options available against this microorganism are limited. In this scenario, the use of usnic acid (UA), a natural compound, encapsulated into liposomes is proposed as a new approach in multidrug-resistant tuberculosis (MDR-TB) therapy. Thus the aim of this study was to evaluate the effect of the encapsulation of UA into liposomes, as well as its combination with antituberculous agents such as rifampicin (RIF) and isoniazid (INH) against MDR-TB clinical isolates. The in vitro antimycobacterial activity of UA-loaded liposomes (UA-Lipo) against MDR-TB was assessed by the microdilution method. The in vitro interaction of UA with antituberculous agents was carried out using checkerboard method. Minimal inhibitory concentration values were 31.25 and 0.98 µg/mL for UA and UA-Lipo, respectively. The results exhibited a synergistic interaction between RIF and UA [fractional inhibitory concentration index (FICI) = 0.31] or UA-Lipo (FICI = 0.28). Regarding INH, the combination of UA or UA-Lipo revealed no marked effect (FICI = 1.30-2.50). The UA-Lipo may be used as a dosage form to improve the antimycobacterial activity of RIF, a first-line drug for the treatment of infections caused by Mtb.
- 29 April 2016
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 111 (5) , 330-334
Open AccessEffects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates
Mycobacterium tuberculosis (Mtb) has acquired resistance and consequently the antibiotic therapeutic options available against this microorganism are limited. In this scenario, the use of usnic acid (UA), a natural compound, encapsulated into liposomes is proposed as a new approach in multidrug-resistant tuberculosis (MDR-TB) therapy. Thus the aim of this study was to evaluate the effect of the encapsulation of UA into liposomes, as well as its combination with antituberculous agents such as rifampicin (RIF) and isoniazid (INH) against MDR-TB clinical isolates. The in vitro antimycobacterial activity of UA-loaded liposomes (UA-Lipo) against MDR-TB was assessed by the microdilution method. The in vitro interaction of UA with antituberculous agents was carried out using checkerboard method. Minimal inhibitory concentration values were 31.25 and 0.98 µg/mL for UA and UA-Lipo, respectively. The results exhibited a synergistic interaction between RIF and UA [fractional inhibitory concentration index (FICI) = 0.31] or UA-Lipo (FICI = 0.28). Regarding INH, the combination of UA or UA-Lipo revealed no marked effect (FICI = 1.30-2.50). The UA-Lipo may be used as a dosage form to improve the antimycobacterial activity of RIF, a first-line drug for the treatment of infections caused by Mtb.